Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study

Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study

Nan Su,1,2 Lili Zhi,3 Fengxia Liu,4 Yongsheng Wang,5 Qingling Zhang,6 Xiansheng Liu,7 Xueyan Wang,8 Guodong Hao,9 Xiuqin Zhang,10 Qiang Hu,11 Monica Ligueros-Saylan,12 Alkaz Uddin,13 Jing Yang,14 Tiantian Liang,15 Liju Ding,16 Runqin Li,17 Chen Wang1,2,18– 21 1Department of Pulmonary and Critical Ca...

Full description

Bibliographic Details
Main Authors: Su N, Zhi L, Liu F, Wang Y, Zhang Q, Liu X, Wang X, Hao G, Zhang X, Hu Q, Ligueros-Saylan M, Uddin A, Yang J, Liang T, Ding L, Li R, Wang C
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:Journal of Asthma and Allergy
Subjects:
adverse drug events
allergic asthma
safety
effectiveness
omalizumab
Online Access:https://www.dovepress.com/real-world-safety-and-effectiveness-of-omalizumab-in-moderate-to-sever-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/real-world-safety-and-effectiveness-of-omalizumab-in-moderate-to-sever-peer-reviewed-fulltext-article-JAA

Similar Items